Aspergillosis is a fungal infection caused by Aspergillus mold spores that can lead to allergic reactions or invasive lung infections, particularly in individuals with compromised immune systems or chronic lung issues.
Hyperbaric oxygen therapy may potentially enhance the efficacy of antifungal drugs in combating Aspergillosis by increasing oxygen levels and improving the immune system’s ability to fight fungal infections.